Skip to main content
Top

Diabetology & Metabolic Syndrome

2009 - 2024
Volumes
19
Issues
Chevron right icon
Issue 1/2024
Latest issue

About this journal

A fully open access journal publishing the most contemporary research on all aspects of diabetes and metabolic dysfunction. An internationally recognized resource for health care providers who strive to improve the management of people affected by these conditions by increasing knowledge and stimulating research in the field.

A journal devoted to basic research and clinical studies in the areas of genetics, pathophysiology, immunology, epidemiology, clinical management, therapeutic strategies, education, nutrition, and psychosocial research relevant for the study of diabetes and metabolic syndrome.

Metadata
Title
Diabetology & Metabolic Syndrome
Coverage
Volume 1/2009 - Volume 16/2024
Publisher
BioMed Central
Electronic ISSN
1758-5996
Journal ID
13098
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare